0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biologics Contract Manufacturing Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-7Z10894
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biologics Contract Manufacturing Market Research Report 2022
BUY CHAPTERS

Global Biologics Contract Manufacturing Market Research Report 2025

Code: QYRE-Auto-7Z10894
Report
February 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biologics Contract Manufacturing Market

The global market for Biologics Contract Manufacturing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Contract manufacturing is a type of outsourcing in which a company enters into an agreement or legal agreement for a product, part or component with another manufacturing company, who then uses that agreement or legal settlement of the product in its production process. This involves the manufacture of biopharmaceutical molecules, proteins, nucleic acids, blood components and vaccines developed from biological sources. These companies specialize in the production of molecules and provide different types of services such as development processes, analysis, and quality control.
North American market for Biologics Contract Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Biologics Contract Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Biologics Contract Manufacturing in Medical Company is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Biologics Contract Manufacturing include Lonza Group, Samsung Biologics Co., Ltd., Thermo Fisher Scientific, Inc., Cambrex Corporation, Siegfried Holding AG, Fujifilm Holding Corporation, AbbVie, Inc., Boehringer Ingelheim, Recipharm Pharmaceuticals, WuXi Biologics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biologics Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics Contract Manufacturing.
The Biologics Contract Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biologics Contract Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics Contract Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Biologics Contract Manufacturing Market Report

Report Metric Details
Report Name Biologics Contract Manufacturing Market
Segment by Type
Segment by Application
  • Medical Company
  • Hospital
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Lonza Group, Samsung Biologics Co., Ltd., Thermo Fisher Scientific, Inc., Cambrex Corporation, Siegfried Holding AG, Fujifilm Holding Corporation, AbbVie, Inc., Boehringer Ingelheim, Recipharm Pharmaceuticals, WuXi Biologics, Catalent, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Biologics Contract Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Biologics Contract Manufacturing Market report?

Ans: The main players in the Biologics Contract Manufacturing Market are Lonza Group, Samsung Biologics Co., Ltd., Thermo Fisher Scientific, Inc., Cambrex Corporation, Siegfried Holding AG, Fujifilm Holding Corporation, AbbVie, Inc., Boehringer Ingelheim, Recipharm Pharmaceuticals, WuXi Biologics, Catalent, Inc.

What are the Application segmentation covered in the Biologics Contract Manufacturing Market report?

Ans: The Applications covered in the Biologics Contract Manufacturing Market report are Medical Company, Hospital

What are the Type segmentation covered in the Biologics Contract Manufacturing Market report?

Ans: The Types covered in the Biologics Contract Manufacturing Market report are Monoclonal Antibodies, Recombinant Proteins, Vaccines, Molecular Therapy, Others

Recommended Reports

Biologics Outsourcing

Biopharmaceutical Manufacturing

Diagnostics & Therapeutics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologics Contract Manufacturing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Recombinant Proteins
1.2.4 Vaccines
1.2.5 Molecular Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Biologics Contract Manufacturing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Medical Company
1.3.3 Hospital
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologics Contract Manufacturing Market Perspective (2020-2031)
2.2 Global Biologics Contract Manufacturing Growth Trends by Region
2.2.1 Global Biologics Contract Manufacturing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biologics Contract Manufacturing Historic Market Size by Region (2020-2025)
2.2.3 Biologics Contract Manufacturing Forecasted Market Size by Region (2026-2031)
2.3 Biologics Contract Manufacturing Market Dynamics
2.3.1 Biologics Contract Manufacturing Industry Trends
2.3.2 Biologics Contract Manufacturing Market Drivers
2.3.3 Biologics Contract Manufacturing Market Challenges
2.3.4 Biologics Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologics Contract Manufacturing Players by Revenue
3.1.1 Global Top Biologics Contract Manufacturing Players by Revenue (2020-2025)
3.1.2 Global Biologics Contract Manufacturing Revenue Market Share by Players (2020-2025)
3.2 Global Biologics Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biologics Contract Manufacturing Revenue
3.4 Global Biologics Contract Manufacturing Market Concentration Ratio
3.4.1 Global Biologics Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics Contract Manufacturing Revenue in 2024
3.5 Global Key Players of Biologics Contract Manufacturing Head office and Area Served
3.6 Global Key Players of Biologics Contract Manufacturing, Product and Application
3.7 Global Key Players of Biologics Contract Manufacturing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics Contract Manufacturing Breakdown Data by Type
4.1 Global Biologics Contract Manufacturing Historic Market Size by Type (2020-2025)
4.2 Global Biologics Contract Manufacturing Forecasted Market Size by Type (2026-2031)
5 Biologics Contract Manufacturing Breakdown Data by Application
5.1 Global Biologics Contract Manufacturing Historic Market Size by Application (2020-2025)
5.2 Global Biologics Contract Manufacturing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biologics Contract Manufacturing Market Size (2020-2031)
6.2 North America Biologics Contract Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biologics Contract Manufacturing Market Size by Country (2020-2025)
6.4 North America Biologics Contract Manufacturing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologics Contract Manufacturing Market Size (2020-2031)
7.2 Europe Biologics Contract Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biologics Contract Manufacturing Market Size by Country (2020-2025)
7.4 Europe Biologics Contract Manufacturing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologics Contract Manufacturing Market Size (2020-2031)
8.2 Asia-Pacific Biologics Contract Manufacturing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biologics Contract Manufacturing Market Size by Region (2020-2025)
8.4 Asia-Pacific Biologics Contract Manufacturing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologics Contract Manufacturing Market Size (2020-2031)
9.2 Latin America Biologics Contract Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biologics Contract Manufacturing Market Size by Country (2020-2025)
9.4 Latin America Biologics Contract Manufacturing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologics Contract Manufacturing Market Size (2020-2031)
10.2 Middle East & Africa Biologics Contract Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biologics Contract Manufacturing Market Size by Country (2020-2025)
10.4 Middle East & Africa Biologics Contract Manufacturing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza Group
11.1.1 Lonza Group Company Details
11.1.2 Lonza Group Business Overview
11.1.3 Lonza Group Biologics Contract Manufacturing Introduction
11.1.4 Lonza Group Revenue in Biologics Contract Manufacturing Business (2020-2025)
11.1.5 Lonza Group Recent Development
11.2 Samsung Biologics Co., Ltd.
11.2.1 Samsung Biologics Co., Ltd. Company Details
11.2.2 Samsung Biologics Co., Ltd. Business Overview
11.2.3 Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Introduction
11.2.4 Samsung Biologics Co., Ltd. Revenue in Biologics Contract Manufacturing Business (2020-2025)
11.2.5 Samsung Biologics Co., Ltd. Recent Development
11.3 Thermo Fisher Scientific, Inc.
11.3.1 Thermo Fisher Scientific, Inc. Company Details
11.3.2 Thermo Fisher Scientific, Inc. Business Overview
11.3.3 Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Introduction
11.3.4 Thermo Fisher Scientific, Inc. Revenue in Biologics Contract Manufacturing Business (2020-2025)
11.3.5 Thermo Fisher Scientific, Inc. Recent Development
11.4 Cambrex Corporation
11.4.1 Cambrex Corporation Company Details
11.4.2 Cambrex Corporation Business Overview
11.4.3 Cambrex Corporation Biologics Contract Manufacturing Introduction
11.4.4 Cambrex Corporation Revenue in Biologics Contract Manufacturing Business (2020-2025)
11.4.5 Cambrex Corporation Recent Development
11.5 Siegfried Holding AG
11.5.1 Siegfried Holding AG Company Details
11.5.2 Siegfried Holding AG Business Overview
11.5.3 Siegfried Holding AG Biologics Contract Manufacturing Introduction
11.5.4 Siegfried Holding AG Revenue in Biologics Contract Manufacturing Business (2020-2025)
11.5.5 Siegfried Holding AG Recent Development
11.6 Fujifilm Holding Corporation
11.6.1 Fujifilm Holding Corporation Company Details
11.6.2 Fujifilm Holding Corporation Business Overview
11.6.3 Fujifilm Holding Corporation Biologics Contract Manufacturing Introduction
11.6.4 Fujifilm Holding Corporation Revenue in Biologics Contract Manufacturing Business (2020-2025)
11.6.5 Fujifilm Holding Corporation Recent Development
11.7 AbbVie, Inc.
11.7.1 AbbVie, Inc. Company Details
11.7.2 AbbVie, Inc. Business Overview
11.7.3 AbbVie, Inc. Biologics Contract Manufacturing Introduction
11.7.4 AbbVie, Inc. Revenue in Biologics Contract Manufacturing Business (2020-2025)
11.7.5 AbbVie, Inc. Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Biologics Contract Manufacturing Introduction
11.8.4 Boehringer Ingelheim Revenue in Biologics Contract Manufacturing Business (2020-2025)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Recipharm Pharmaceuticals
11.9.1 Recipharm Pharmaceuticals Company Details
11.9.2 Recipharm Pharmaceuticals Business Overview
11.9.3 Recipharm Pharmaceuticals Biologics Contract Manufacturing Introduction
11.9.4 Recipharm Pharmaceuticals Revenue in Biologics Contract Manufacturing Business (2020-2025)
11.9.5 Recipharm Pharmaceuticals Recent Development
11.10 WuXi Biologics
11.10.1 WuXi Biologics Company Details
11.10.2 WuXi Biologics Business Overview
11.10.3 WuXi Biologics Biologics Contract Manufacturing Introduction
11.10.4 WuXi Biologics Revenue in Biologics Contract Manufacturing Business (2020-2025)
11.10.5 WuXi Biologics Recent Development
11.11 Catalent, Inc.
11.11.1 Catalent, Inc. Company Details
11.11.2 Catalent, Inc. Business Overview
11.11.3 Catalent, Inc. Biologics Contract Manufacturing Introduction
11.11.4 Catalent, Inc. Revenue in Biologics Contract Manufacturing Business (2020-2025)
11.11.5 Catalent, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Biologics Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Monoclonal Antibodies
 Table 3. Key Players of Recombinant Proteins
 Table 4. Key Players of Vaccines
 Table 5. Key Players of Molecular Therapy
 Table 6. Key Players of Others
 Table 7. Global Biologics Contract Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Biologics Contract Manufacturing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Biologics Contract Manufacturing Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Biologics Contract Manufacturing Market Share by Region (2020-2025)
 Table 11. Global Biologics Contract Manufacturing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Biologics Contract Manufacturing Market Share by Region (2026-2031)
 Table 13. Biologics Contract Manufacturing Market Trends
 Table 14. Biologics Contract Manufacturing Market Drivers
 Table 15. Biologics Contract Manufacturing Market Challenges
 Table 16. Biologics Contract Manufacturing Market Restraints
 Table 17. Global Biologics Contract Manufacturing Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Biologics Contract Manufacturing Market Share by Players (2020-2025)
 Table 19. Global Top Biologics Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Contract Manufacturing as of 2024)
 Table 20. Ranking of Global Top Biologics Contract Manufacturing Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Biologics Contract Manufacturing Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Biologics Contract Manufacturing, Headquarters and Area Served
 Table 23. Global Key Players of Biologics Contract Manufacturing, Product and Application
 Table 24. Global Key Players of Biologics Contract Manufacturing, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Biologics Contract Manufacturing Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Biologics Contract Manufacturing Revenue Market Share by Type (2020-2025)
 Table 28. Global Biologics Contract Manufacturing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Biologics Contract Manufacturing Revenue Market Share by Type (2026-2031)
 Table 30. Global Biologics Contract Manufacturing Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Biologics Contract Manufacturing Revenue Market Share by Application (2020-2025)
 Table 32. Global Biologics Contract Manufacturing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Biologics Contract Manufacturing Revenue Market Share by Application (2026-2031)
 Table 34. North America Biologics Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Biologics Contract Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Biologics Contract Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Biologics Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Biologics Contract Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Biologics Contract Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Biologics Contract Manufacturing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Biologics Contract Manufacturing Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Biologics Contract Manufacturing Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Biologics Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Biologics Contract Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Biologics Contract Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Biologics Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Biologics Contract Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Biologics Contract Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Lonza Group Company Details
 Table 50. Lonza Group Business Overview
 Table 51. Lonza Group Biologics Contract Manufacturing Product
 Table 52. Lonza Group Revenue in Biologics Contract Manufacturing Business (2020-2025) & (US$ Million)
 Table 53. Lonza Group Recent Development
 Table 54. Samsung Biologics Co., Ltd. Company Details
 Table 55. Samsung Biologics Co., Ltd. Business Overview
 Table 56. Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Product
 Table 57. Samsung Biologics Co., Ltd. Revenue in Biologics Contract Manufacturing Business (2020-2025) & (US$ Million)
 Table 58. Samsung Biologics Co., Ltd. Recent Development
 Table 59. Thermo Fisher Scientific, Inc. Company Details
 Table 60. Thermo Fisher Scientific, Inc. Business Overview
 Table 61. Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Product
 Table 62. Thermo Fisher Scientific, Inc. Revenue in Biologics Contract Manufacturing Business (2020-2025) & (US$ Million)
 Table 63. Thermo Fisher Scientific, Inc. Recent Development
 Table 64. Cambrex Corporation Company Details
 Table 65. Cambrex Corporation Business Overview
 Table 66. Cambrex Corporation Biologics Contract Manufacturing Product
 Table 67. Cambrex Corporation Revenue in Biologics Contract Manufacturing Business (2020-2025) & (US$ Million)
 Table 68. Cambrex Corporation Recent Development
 Table 69. Siegfried Holding AG Company Details
 Table 70. Siegfried Holding AG Business Overview
 Table 71. Siegfried Holding AG Biologics Contract Manufacturing Product
 Table 72. Siegfried Holding AG Revenue in Biologics Contract Manufacturing Business (2020-2025) & (US$ Million)
 Table 73. Siegfried Holding AG Recent Development
 Table 74. Fujifilm Holding Corporation Company Details
 Table 75. Fujifilm Holding Corporation Business Overview
 Table 76. Fujifilm Holding Corporation Biologics Contract Manufacturing Product
 Table 77. Fujifilm Holding Corporation Revenue in Biologics Contract Manufacturing Business (2020-2025) & (US$ Million)
 Table 78. Fujifilm Holding Corporation Recent Development
 Table 79. AbbVie, Inc. Company Details
 Table 80. AbbVie, Inc. Business Overview
 Table 81. AbbVie, Inc. Biologics Contract Manufacturing Product
 Table 82. AbbVie, Inc. Revenue in Biologics Contract Manufacturing Business (2020-2025) & (US$ Million)
 Table 83. AbbVie, Inc. Recent Development
 Table 84. Boehringer Ingelheim Company Details
 Table 85. Boehringer Ingelheim Business Overview
 Table 86. Boehringer Ingelheim Biologics Contract Manufacturing Product
 Table 87. Boehringer Ingelheim Revenue in Biologics Contract Manufacturing Business (2020-2025) & (US$ Million)
 Table 88. Boehringer Ingelheim Recent Development
 Table 89. Recipharm Pharmaceuticals Company Details
 Table 90. Recipharm Pharmaceuticals Business Overview
 Table 91. Recipharm Pharmaceuticals Biologics Contract Manufacturing Product
 Table 92. Recipharm Pharmaceuticals Revenue in Biologics Contract Manufacturing Business (2020-2025) & (US$ Million)
 Table 93. Recipharm Pharmaceuticals Recent Development
 Table 94. WuXi Biologics Company Details
 Table 95. WuXi Biologics Business Overview
 Table 96. WuXi Biologics Biologics Contract Manufacturing Product
 Table 97. WuXi Biologics Revenue in Biologics Contract Manufacturing Business (2020-2025) & (US$ Million)
 Table 98. WuXi Biologics Recent Development
 Table 99. Catalent, Inc. Company Details
 Table 100. Catalent, Inc. Business Overview
 Table 101. Catalent, Inc. Biologics Contract Manufacturing Product
 Table 102. Catalent, Inc. Revenue in Biologics Contract Manufacturing Business (2020-2025) & (US$ Million)
 Table 103. Catalent, Inc. Recent Development
 Table 104. Research Programs/Design for This Report
 Table 105. Key Data Information from Secondary Sources
 Table 106. Key Data Information from Primary Sources
 Table 107. Authors List of This Report


List of Figures
 Figure 1. Biologics Contract Manufacturing Picture
 Figure 2. Global Biologics Contract Manufacturing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biologics Contract Manufacturing Market Share by Type: 2024 VS 2031
 Figure 4. Monoclonal Antibodies Features
 Figure 5. Recombinant Proteins Features
 Figure 6. Vaccines Features
 Figure 7. Molecular Therapy Features
 Figure 8. Others Features
 Figure 9. Global Biologics Contract Manufacturing Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Biologics Contract Manufacturing Market Share by Application: 2024 VS 2031
 Figure 11. Medical Company Case Studies
 Figure 12. Hospital Case Studies
 Figure 13. Biologics Contract Manufacturing Report Years Considered
 Figure 14. Global Biologics Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Biologics Contract Manufacturing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Biologics Contract Manufacturing Market Share by Region: 2024 VS 2031
 Figure 17. Global Biologics Contract Manufacturing Market Share by Players in 2024
 Figure 18. Global Top Biologics Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Contract Manufacturing as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Biologics Contract Manufacturing Revenue in 2024
 Figure 20. North America Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Biologics Contract Manufacturing Market Share by Country (2020-2031)
 Figure 22. United States Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Biologics Contract Manufacturing Market Share by Country (2020-2031)
 Figure 26. Germany Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Biologics Contract Manufacturing Market Share by Region (2020-2031)
 Figure 34. China Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Biologics Contract Manufacturing Market Share by Country (2020-2031)
 Figure 42. Mexico Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Biologics Contract Manufacturing Market Share by Country (2020-2031)
 Figure 46. Turkey Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Biologics Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Lonza Group Revenue Growth Rate in Biologics Contract Manufacturing Business (2020-2025)
 Figure 50. Samsung Biologics Co., Ltd. Revenue Growth Rate in Biologics Contract Manufacturing Business (2020-2025)
 Figure 51. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Biologics Contract Manufacturing Business (2020-2025)
 Figure 52. Cambrex Corporation Revenue Growth Rate in Biologics Contract Manufacturing Business (2020-2025)
 Figure 53. Siegfried Holding AG Revenue Growth Rate in Biologics Contract Manufacturing Business (2020-2025)
 Figure 54. Fujifilm Holding Corporation Revenue Growth Rate in Biologics Contract Manufacturing Business (2020-2025)
 Figure 55. AbbVie, Inc. Revenue Growth Rate in Biologics Contract Manufacturing Business (2020-2025)
 Figure 56. Boehringer Ingelheim Revenue Growth Rate in Biologics Contract Manufacturing Business (2020-2025)
 Figure 57. Recipharm Pharmaceuticals Revenue Growth Rate in Biologics Contract Manufacturing Business (2020-2025)
 Figure 58. WuXi Biologics Revenue Growth Rate in Biologics Contract Manufacturing Business (2020-2025)
 Figure 59. Catalent, Inc. Revenue Growth Rate in Biologics Contract Manufacturing Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart